Advertisement
UK markets close in 3 hours 20 minutes
  • FTSE 100

    8,117.98
    +39.12 (+0.48%)
     
  • FTSE 250

    19,809.60
    +207.62 (+1.06%)
     
  • AIM

    754.92
    +1.80 (+0.24%)
     
  • GBP/EUR

    1.1676
    +0.0019 (+0.17%)
     
  • GBP/USD

    1.2510
    -0.0001 (-0.01%)
     
  • Bitcoin GBP

    51,394.07
    +403.39 (+0.79%)
     
  • CMC Crypto 200

    1,386.01
    -10.52 (-0.75%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CRUDE OIL

    84.11
    +0.54 (+0.65%)
     
  • GOLD FUTURES

    2,356.40
    +13.90 (+0.59%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,051.16
    +133.88 (+0.75%)
     
  • CAC 40

    8,045.30
    +28.65 (+0.36%)
     

TUWOY's Merger Plans Ditched by Capricorn for Israel's NewMed

The British oil and gas exploration and development company — Capricorn Energy — has abandoned its merger plans with Tullow Oil Plc TUWOY in favor of a deal with the Israeli natural gas group NewMed Energy.

The all-stock deal between Capricorn and NewMed will lead to the creation of an Israel-Egypt-focused gas producer. This will include NewMed's interest in Israel's giant Leviathan offshore field at a time when Europe is hustling for non-Russian energy supplies.

Per the deal, NewMed shareholders will get 2.337344 new Capricorn shares for each of their existing units. Capricorn shareholders will hold about 10.3% of the combined entity with NewMed stockholders, along with the partnership’s current general partner owning the remaining interest.

Additionally, Capricorn shareholders will also receive a cash special dividend of around $620 million before the business combination.

ADVERTISEMENT

This announcement comes weeks after Tullow stated that it was “fully committed” to the earlier declared all-stock deal with Capricorn. The deal would have led to the formation of a £1.4 billion Africa-focused energy company despite Capricorn looking for alternatives following shareholders’ opposition to its merger with Tullow.

The Capricorn-NewMed merger is anticipated to be wound up in the first quarter of 2023, subject to shareholders’ approval from both firms.

The U.K.-based, West Africa-focused Tullow Oil operates as an independent oil and gas exploration and production company in Europe. The company has a large portfolio of exploration and production assets, with a focus on balanced long-term growth. It is headquartered in London, the United Kingdom.

Tullow currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks from the energy space that warrant a look include HF Sinclair DINO, Earthstone Energy ESTE and Murphy USA MUSA, each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for HF Sinclair’s 2022 earnings has been revised about 18.1% upward over the past 60 days from $12.07 per share to $14.26.

The consensus estimate for DINO’s 2022 earnings is pegged at $14.26 per share, up 838.2% from the year-ago earnings of $1.52.

The Zacks Consensus Estimate for Earthstone’s 2022 earnings is pegged at $5.85 per share, indicating an increase of about 368% from the year-ago earnings of $1.25.

ESTE beat the Zacks Consensus Estimate for earnings in all the trailing four quarters, the average being around 27%.

The Zacks Consensus Estimate for Murphy USA’s 2022 EPS has been revised upward by about 14% over the past 60 days from $21.39 to $24.38.

MUSA beat the Zacks Consensus Estimate for earnings in all the trailing four quarters, the average being 49%.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Murphy USA Inc. (MUSA) : Free Stock Analysis Report
 
Tullow Oil PLC (TUWOY) : Free Stock Analysis Report
 
Earthstone Energy, Inc. (ESTE) : Free Stock Analysis Report
 
HF Sinclair Corporation (DINO) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research